Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Penn-Nicholson

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Optimal processing of tongue swab samples for Mycobacterium tuberculosis detection by the Xpert MTB/RIF Ultra assayGayatri Shankar Chilambi, Robert Reiss, Naranjargal Daivaa, et al.
Tuberculosis (Edinburgh, Scotland)|July 28, 2016
Epidemiologic studies and novel clinical research approaches that impact TB vaccine developmentThomas G Evans, Gavin J Churchyard, Adam Penn-Nicholson, et al.
Medrxiv : the Preprint Server for Health Sciences|March 13, 2026
In-home molecular testing of tongue swabs and sputum to inform household-level screening with diagnostic escalation strategies for tuberculosis contact investigation: a prospective cohort study in South AfricaAndrew Medina-Marino, Sharon Olifant, Maria Pieruccini, et al.
Virology|December 11, 2007
Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelopeAdam Penn-Nicholson, Dong P Han, Soon J Kim, et al.
Frontiers in Public Health|July 14, 2025
Performance evaluation of the Molbio diagnostics Truenat MTB Ultima/COVID-19 multiplex assay for TB and COVID-19 case detection among people with symptoms suggestive of tuberculosis-a study protocol for clinical trialsManju Purohit, Willy Ssengooba, Helen Cox, et al.
Open Forum Infectious Diseases|June 13, 2024
In-home TB Testing Using GeneXpert Edge is Acceptable, Feasible, and Improves the Proportion of Symptomatic Household Contacts Tested for TB: A Proof-of-Concept StudyAndrew Medina-Marino, Dana Bezuidenhout, Charl Bezuidenhout, et al.
BMJ Open|May 25, 2019
Performance of host blood transcriptomic signatures for diagnosing and predicting progression to tuberculosis disease in HIV-negative adults and adolescents: a systematic review protocolHumphrey Mulenga, Erick Wekesa Bunyasi, Stanley Kimbung Mbandi, et al.
Virology|July 22, 2014
Eliciting neutralizing antibodies with gp120 outer domain constructs based on M-group consensus sequenceYali Qin, Marisa Banasik, SoonJeung Kim, et al.
Frontiers in Cellular and Infection Microbiology|September 12, 2019
Plasma Type I IFN Protein Concentrations in Human TuberculosisAlba Llibre, Nicole Bilek, Vincent Bondet, et al.
Clinical and Vaccine Immunology : CVI|September 25, 2009
A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunityDavid H Holman, Adam Penn-Nicholson, Danher Wang, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Optimal processing of tongue swab samples for Mycobacterium tuberculosis detection by the Xpert MTB/RIF Ultra assayGayatri Shankar Chilambi, Robert Reiss, Naranjargal Daivaa, et al.
Tuberculosis (Edinburgh, Scotland)|July 28, 2016
Epidemiologic studies and novel clinical research approaches that impact TB vaccine developmentThomas G Evans, Gavin J Churchyard, Adam Penn-Nicholson, et al.
Medrxiv : the Preprint Server for Health Sciences|March 13, 2026
In-home molecular testing of tongue swabs and sputum to inform household-level screening with diagnostic escalation strategies for tuberculosis contact investigation: a prospective cohort study in South AfricaAndrew Medina-Marino, Sharon Olifant, Maria Pieruccini, et al.
Virology|December 11, 2007
Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelopeAdam Penn-Nicholson, Dong P Han, Soon J Kim, et al.
Frontiers in Public Health|July 14, 2025
Performance evaluation of the Molbio diagnostics Truenat MTB Ultima/COVID-19 multiplex assay for TB and COVID-19 case detection among people with symptoms suggestive of tuberculosis-a study protocol for clinical trialsManju Purohit, Willy Ssengooba, Helen Cox, et al.
Open Forum Infectious Diseases|June 13, 2024
In-home TB Testing Using GeneXpert Edge is Acceptable, Feasible, and Improves the Proportion of Symptomatic Household Contacts Tested for TB: A Proof-of-Concept StudyAndrew Medina-Marino, Dana Bezuidenhout, Charl Bezuidenhout, et al.
BMJ Open|May 25, 2019
Performance of host blood transcriptomic signatures for diagnosing and predicting progression to tuberculosis disease in HIV-negative adults and adolescents: a systematic review protocolHumphrey Mulenga, Erick Wekesa Bunyasi, Stanley Kimbung Mbandi, et al.
Virology|July 22, 2014
Eliciting neutralizing antibodies with gp120 outer domain constructs based on M-group consensus sequenceYali Qin, Marisa Banasik, SoonJeung Kim, et al.
Frontiers in Cellular and Infection Microbiology|September 12, 2019
Plasma Type I IFN Protein Concentrations in Human TuberculosisAlba Llibre, Nicole Bilek, Vincent Bondet, et al.
Clinical and Vaccine Immunology : CVI|September 25, 2009
A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunityDavid H Holman, Adam Penn-Nicholson, Danher Wang, et al.
Pageof 10